Financing
Debt Issuance Costs
Moderna Debt Issuance Costs remained flat by 0.0% to $5.5M in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 20, 2026
How to read this metric
Higher costs relative to the debt issued may indicate unfavorable market conditions or higher risk premiums demanded by lenders.
Detailed definition
Cash outflows associated with the fees and expenses incurred when raising debt capital, such as underwriting fees, legal...
Peer comparison
Standard across all industries; costs typically scale proportionally with the size and complexity of the debt offering.
Metric ID:
payment_of_debt_issuance_costsHistorical Data
3 years
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $0 | $0 | $22M |
Range$0 – $22M
Debt Issuance Costs at Other Companies
Frequently Asked Questions
- What is Moderna's debt issuance costs?
- Moderna (MRNA) reported debt issuance costs of $5.5M in Q4 2025.
- What does debt issuance costs mean?
- Cash paid to cover the fees and costs of borrowing money.